Clonazepam 0.25 MG Disintegrating Oral Tablet — RxCUI 349195
RxNorm drug concept · Semantic clinical drug
RxCUI 349195
Semantic clinical drug · SCD
● Current RxNorm concept 25 FDA products
30 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI349195
Official nameClonazepam 0.25 MG Disintegrating Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped25
Package NDCs mapped30
Reported Medicaid activity (SDUD)142,755 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Clonazepam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats certain seizure disorders and panic disorder. Your prescriber will tell you which applies to you.
- Take it by mouth exactly as prescribed. Swallow regular tablets whole with water. If you have the orally disintegrating tablet, place it on your tongue with dry hands and let it di...
- Please don't stop suddenly. Your body can become dependent, and abrupt stopping can cause serious withdrawal, including seizures. Your prescriber will lower the dose gradually.
- Drowsiness, unsteadiness and dizziness are the most common. Let me know if you notice mood changes, depression, thoughts of self-harm, agitation or aggression, because those need p...
🕸️ Concept Web — How Clonazepam 0.25 MG Disintegrating Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Clonazepam 0.25 MG Disintegrating Oral Tablet
RxCUI 349195 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Clonazepam
2598IN
-
Clonazepam
-
Dose forms 8
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Clonazepam Disintegrating Oral Tablet
380918SCDF -
Clonazepam Disintegrating Oral Product
1295321SCDG -
Clonazepam Oral Product
1153378SCDG -
Clonazepam Pill
1153379SCDG -
Disintegrating Oral Tablet
316942DF -
Disintegrating Oral Product
1294713DFG -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Clonazepam Disintegrating Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Clonazepam 0.25 MG
329147SCDC
-
Clonazepam 0.25 MG
Showing up to 8 concepts per family — 10 of 10 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Clonazepam 0.25 MG
SCDC · 329147 -
Clonazepam Disintegrating Oral Tablet
SCDF · 380918 -
Clonazepam Disintegrating Oral Product
SCDG · 1295321 -
Clonazepam Oral Product
SCDG · 1153378 -
Clonazepam Pill
SCDG · 1153379
📦 FDA Products & Package NDCs
25 products · 30 package NDCs
30 package NDCs map to RxCUI 349195 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-9290-67 | 60 BLISTER PACK in 1 CARTON (0093-9290-67) / 1 TABLET, ORAL... | Clonazepam | Teva Pharmaceuticals USA, Inc. | 2022-03-02 |
| 00093-9291-67 | 60 BLISTER PACK in 1 CARTON (0093-9291-67) / 1 TABLET, ORAL... | Clonazepam | Teva Pharmaceuticals USA, Inc. | 2022-03-02 |
| 00093-9292-67 | 60 BLISTER PACK in 1 CARTON (0093-9292-67) / 1 TABLET, ORAL... | Clonazepam | Teva Pharmaceuticals USA, Inc. | 2022-03-02 |
| 00093-9293-67 | 60 BLISTER PACK in 1 CARTON (0093-9293-67) / 1 TABLET, ORAL... | Clonazepam | Teva Pharmaceuticals USA, Inc. | 2021-11-22 |
| 00093-9294-67 | 60 BLISTER PACK in 1 CARTON (0093-9294-67) / 1 TABLET, ORAL... | Clonazepam | Teva Pharmaceuticals USA, Inc. | 2022-03-02 |
| 46708-0364-06 | 60 BLISTER PACK in 1 CARTON (46708-364-06) / 6 TABLET, ORAL... | CLONAZEPAM | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0365-06 | 60 BLISTER PACK in 1 CARTON (46708-365-06) / 6 TABLET, ORAL... | CLONAZEPAM | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0366-06 | 60 BLISTER PACK in 1 CARTON (46708-366-06) / 6 TABLET, ORAL... | CLONAZEPAM | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0367-06 | 60 BLISTER PACK in 1 CARTON (46708-367-06) / 6 TABLET, ORAL... | CLONAZEPAM | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 46708-0368-06 | 60 BLISTER PACK in 1 CARTON (46708-368-06) / 6 TABLET, ORAL... | CLONAZEPAM | Alembic Pharmaceuticals Limited | 2019-07-01 |
| 49884-0306-02 | 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (49884-30... | Clonazepam | Par Health USA, LLC | 2005-08-05 |
| 49884-0307-02 | 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (49884-30... | Clonazepam | Par Health USA, LLC | 2005-08-05 |
| 49884-0308-02 | 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (49884-30... | Clonazepam | Par Health USA, LLC | 2005-08-05 |
| 49884-0309-02 | 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (49884-30... | Clonazepam | Par Health USA, LLC | 2005-08-05 |
| 49884-0310-02 | 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (49884-31... | Clonazepam | Par Health USA, LLC | 2005-08-05 |
| 62332-0364-06 | 60 BLISTER PACK in 1 CARTON (62332-364-06) / 6 TABLET, ORAL... | CLONAZEPAM | Alembic Pharmaceuticals Inc. | 2019-07-01 |
| 62332-0365-06 | 60 BLISTER PACK in 1 CARTON (62332-365-06) / 6 TABLET, ORAL... | CLONAZEPAM | Alembic Pharmaceuticals Inc. | 2019-07-01 |
| 62332-0366-06 | 60 BLISTER PACK in 1 CARTON (62332-366-06) / 6 TABLET, ORAL... | CLONAZEPAM | Alembic Pharmaceuticals Inc. | 2019-07-01 |
| 62332-0367-06 | 60 BLISTER PACK in 1 CARTON (62332-367-06) / 6 TABLET, ORAL... | CLONAZEPAM | Alembic Pharmaceuticals Inc. | 2019-07-01 |
| 62332-0368-06 | 60 BLISTER PACK in 1 CARTON (62332-368-06) / 6 TABLET, ORAL... | CLONAZEPAM | Alembic Pharmaceuticals Inc. | 2019-07-01 |
| 72888-0133-29 | 10 TABLET, ORALLY DISINTEGRATING in 1 CARTON (72888-133-29) | clonazepam | Advagen Pharma Ltd | 2026-05-21 |
| 72888-0133-31 | 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (72888-133... | clonazepam | Advagen Pharma Ltd | 2026-05-21 |
| 72888-0134-29 | 10 TABLET, ORALLY DISINTEGRATING in 1 CARTON (72888-134-29) | clonazepam | Advagen Pharma Ltd | 2026-05-21 |
| 72888-0134-31 | 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (72888-134... | clonazepam | Advagen Pharma Ltd | 2026-05-21 |
| 72888-0135-29 | 10 TABLET, ORALLY DISINTEGRATING in 1 CARTON (72888-135-29) | clonazepam | Advagen Pharma Ltd | 2026-05-21 |
| 72888-0135-31 | 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (72888-135... | clonazepam | Advagen Pharma Ltd | 2026-05-21 |
| 72888-0136-29 | 10 TABLET, ORALLY DISINTEGRATING in 1 CARTON (72888-136-29) | clonazepam | Advagen Pharma Ltd | 2026-05-21 |
| 72888-0136-31 | 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (72888-136... | clonazepam | Advagen Pharma Ltd | 2026-05-21 |
| 72888-0137-29 | 10 TABLET, ORALLY DISINTEGRATING in 1 CARTON (72888-137-29) | clonazepam | Advagen Pharma Ltd | 2026-05-21 |
| 72888-0137-31 | 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (72888-137... | clonazepam | Advagen Pharma Ltd | 2026-05-21 |
Observed labelers:
Advagen Pharma Ltd (10) ·
Alembic Pharmaceuticals Inc. (5) ·
Alembic Pharmaceuticals Limited (5) ·
Par Health USA, LLC (5) ·
Teva Pharmaceuticals USA, Inc. (5)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.